Millennium Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-68,000
Closed -$16.7M 7444
2022
Q3
$16.7M Buy
68,000
+16,400
+32% +$4.43M 0.01% 1527
2022
Q2
$12.8M Buy
+51,600
New +$13.9M 0.01% 1748
2022
Q1
Sell
-48,000
Closed -$17.2M 7939
2021
Q4
$17.2M Sell
48,000
-22,000
-31% -$7.43M 0.01% 1584
2021
Q3
$22.8M Buy
70,000
+5,000
+8% +$1.69M 0.01% 1208
2021
Q2
$20.3M Sell
65,000
-18,000
-22% -$5.52M 0.01% 1184
2021
Q1
$26.5M Buy
83,000
+19,000
+30% +$6.08M 0.02% 884
2020
Q4
$20.7M Buy
64,000
+54,000
+540% +$14.9M 0.02% 1038
2020
Q3
$2.77K Buy
10,000
+5,000
+100% +$1.44M ﹤0.01% 2342
2020
Q2
$1.21M Sell
5,000
-65,000
-93% -$13.1M ﹤0.01% 2882
2020
Q1
$10.2M Buy
70,000
+18,000
+35% +$2.99M 0.02% 841
2019
Q4
$8.87M Sell
52,000
-62,100
-54% -$11.5M 0.01% 1476
2019
Q3
$20.3M Buy
114,100
+112,100
+5,605% +$24.2M 0.03% 774
2019
Q2
$521K Sell
2,000
-3,500
-64% -$929K ﹤0.01% 3200
2019
Q1
$1.57M Buy
5,500
+4,500
+450% +$1.5M ﹤0.01% 2569
2018
Q4
$325K Hold
1,000
﹤0.01% 3175
2018
Q3
$450K Hold
1,000
﹤0.01% 3295
2018
Q2
$409K Buy
+1,000
New +$362K ﹤0.01% 3257
2017
Q3
Sell
-5,000
Closed -$717K 3986
2017
Q2
$717K Sell
5,000
-45,000
-90% -$6.05M ﹤0.01% 2621
2017
Q1
$6.26M Buy
+50,000
New +$5.8M 0.01% 1320
2013
Q4
Sell
-12,700
Closed -$242K 3881
2013
Q3
$242K Buy
+12,700
New +$290K ﹤0.01% 2997

Other funds holding ABMD

Millennium Management's ABMD Position: Q4 2022 in Review

Millennium Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 9,614 shares — an estimated $2.36M sold.

Millennium Management first reported a position in ABMD in Q2 2013 and held it in 37 quarters. The position peaked at $85.2M in Q4 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Millennium Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Millennium Management sold 9,614 Abiomed Inc shares in Q4 2022, an estimated $2.36M.
  • Millennium Management first reported a position in Abiomed Inc in Q2 2013 and held it in 37 quarters.
  • Millennium Management's Abiomed Inc position peaked at $85.2M in Q4 2017.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.